Covered recipient · General Payments record
SHANICE MCKENZIE
General Payments · PY2021–2024
$3,201.97
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,135.54 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $500.64 | 5 |
| Dermavant Sciences, Inc. | $321.21 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.93 | 1 |
| GENZYME CORPORATION | $121.41 | 1 |
| Galderma Laboratories, L.P. | $35.25 | 1 |
| REVANCE THERAPEUTICS, INC. | $32.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $114.52 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105005487 | CMS |
| ABBVIE INC. | $124.99 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105005489 | CMS |
| ABBVIE INC. | $27.70 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105005491 | CMS |
| ABBVIE INC. | $122.35 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105005493 | CMS |
| ABBVIE INC. | $111.08 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105005495 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.93 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118055455 | CMS |
| Dermavant Sciences, Inc. | $145.25 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127905351 | CMS |
| Dermavant Sciences, Inc. | $175.96 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127905355 | CMS |
| Galderma Laboratories, L.P. | $35.25 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145315758 | CMS |
| GENZYME CORPORATION | $121.41 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139585738 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.10 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147924262 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.